{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "vscode": {
     "languageId": "plaintext"
    }
   },
   "source": [
    "# Clinical Trials "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pandas in /opt/anaconda3/lib/python3.11/site-packages (2.1.4)\n",
      "Requirement already satisfied: numpy<2,>=1.23.2 in /opt/anaconda3/lib/python3.11/site-packages (from pandas) (1.26.4)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /opt/anaconda3/lib/python3.11/site-packages (from pandas) (2.8.2)\n",
      "Requirement already satisfied: pytz>=2020.1 in /opt/anaconda3/lib/python3.11/site-packages (from pandas) (2023.3.post1)\n",
      "Requirement already satisfied: tzdata>=2022.1 in /opt/anaconda3/lib/python3.11/site-packages (from pandas) (2023.3)\n",
      "Requirement already satisfied: six>=1.5 in /opt/anaconda3/lib/python3.11/site-packages (from python-dateutil>=2.8.2->pandas) (1.16.0)\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "%pip install pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('data/ovarian_cancer.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT06121401</td>\n",
       "      <td>First Line Treatment With Olaparib in Combinat...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT06121401</td>\n",
       "      <td>IOLANTHE</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The goal of this prospective, phase IV, multi-...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Carcinoma, Ovarian Epithelial</td>\n",
       "      <td>DRUG: Olaparib|DRUG: Bevacizumab</td>\n",
       "      <td>Proportion of patients treated with olaparib, ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>IRFMN-OVA-8542</td>\n",
       "      <td>2023-09-15</td>\n",
       "      <td>2027-03-15</td>\n",
       "      <td>2027-09-15</td>\n",
       "      <td>2023-11-07</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-11-07</td>\n",
       "      <td>Azienda Socio Sanitaria Territoriale (ASST) La...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03400306</td>\n",
       "      <td>A Study Evaluating the Bioavailability and Foo...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03400306</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>This study will evaluate the bioavailability b...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cancer - Ovarian</td>\n",
       "      <td>DRUG: Veliparib, capsule|DRUG: Veliparib, tabl...</td>\n",
       "      <td>Maximum observed plasma concentration (Cmax), ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>M15-536|2018-000313-20</td>\n",
       "      <td>2021-11-15</td>\n",
       "      <td>2021-11-16</td>\n",
       "      <td>2021-11-16</td>\n",
       "      <td>2018-01-17</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-12-08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT06703112</td>\n",
       "      <td>Establishment and Clinical Application of AI-b...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT06703112</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>Ovarian tumors are a common disease that threa...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ovarian Tumors</td>\n",
       "      <td>DIAGNOSTIC_TEST: An auxiliary diagnostic model...</td>\n",
       "      <td>Pathological diagnosis, After the surgical spe...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>IIT2024-037-002</td>\n",
       "      <td>2025-06-01</td>\n",
       "      <td>2026-12-31</td>\n",
       "      <td>2026-12-31</td>\n",
       "      <td>2024-11-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-11-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05158062</td>\n",
       "      <td>Pembrolizumab and Bevacizumab With Chemotherap...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05158062</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This trial is a multicenter, single-arm, phase...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Carcinoma, Ovarian Epithelial</td>\n",
       "      <td>BIOLOGICAL: pembrolizumab|DRUG: olaparib|BIOLO...</td>\n",
       "      <td>Two-year progression-free survival rate, Two-y...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>SaINT-ov02</td>\n",
       "      <td>2022-04-20</td>\n",
       "      <td>2024-11-30</td>\n",
       "      <td>2024-11-30</td>\n",
       "      <td>2021-12-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-04-26</td>\n",
       "      <td>Saitama Medical Uiversity International Medica...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT06640348</td>\n",
       "      <td>Ultrasensitive SERS Platform With Highly Effic...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT06640348</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This project is an open, single-center, prospe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ovarian Cancer, Epithelial</td>\n",
       "      <td>OTHER: No intervention</td>\n",
       "      <td>PFS PFS, progression free survival, one year|O...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>YingZhou 2024-10</td>\n",
       "      <td>2025-01-01</td>\n",
       "      <td>2027-12-31</td>\n",
       "      <td>2030-12-31</td>\n",
       "      <td>2024-10-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-10-15</td>\n",
       "      <td>Anhui Provincal Hospital, Hefei, Anhui, China</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT06121401  First Line Treatment With Olaparib in Combinat...   \n",
       "1  NCT03400306  A Study Evaluating the Bioavailability and Foo...   \n",
       "2  NCT06703112  Establishment and Clinical Application of AI-b...   \n",
       "3  NCT05158062  Pembrolizumab and Bevacizumab With Chemotherap...   \n",
       "4  NCT06640348  Ultrasensitive SERS Platform With Highly Effic...   \n",
       "\n",
       "                                      Study URL   Acronym        Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT06121401  IOLANTHE          RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03400306       NaN           WITHDRAWN   \n",
       "2  https://clinicaltrials.gov/study/NCT06703112       NaN  NOT_YET_RECRUITING   \n",
       "3  https://clinicaltrials.gov/study/NCT05158062       NaN             UNKNOWN   \n",
       "4  https://clinicaltrials.gov/study/NCT06640348       NaN          RECRUITING   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  The goal of this prospective, phase IV, multi-...            NO   \n",
       "1  This study will evaluate the bioavailability b...            NO   \n",
       "2  Ovarian tumors are a common disease that threa...            NO   \n",
       "3  This trial is a multicenter, single-arm, phase...            NO   \n",
       "4  This project is an open, single-center, prospe...            NO   \n",
       "\n",
       "                      Conditions  \\\n",
       "0  Carcinoma, Ovarian Epithelial   \n",
       "1               Cancer - Ovarian   \n",
       "2                 Ovarian Tumors   \n",
       "3  Carcinoma, Ovarian Epithelial   \n",
       "4     Ovarian Cancer, Epithelial   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                   DRUG: Olaparib|DRUG: Bevacizumab   \n",
       "1  DRUG: Veliparib, capsule|DRUG: Veliparib, tabl...   \n",
       "2  DIAGNOSTIC_TEST: An auxiliary diagnostic model...   \n",
       "3  BIOLOGICAL: pembrolizumab|DRUG: olaparib|BIOLO...   \n",
       "4                             OTHER: No intervention   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Proportion of patients treated with olaparib, ...  ...   \n",
       "1  Maximum observed plasma concentration (Cmax), ...  ...   \n",
       "2  Pathological diagnosis, After the surgical spe...  ...   \n",
       "3  Two-year progression-free survival rate, Two-y...  ...   \n",
       "4  PFS PFS, progression free survival, one year|O...  ...   \n",
       "\n",
       "                                        Study Design               Other IDs  \\\n",
       "0  Allocation: NA|Intervention Model: SINGLE_GROU...          IRFMN-OVA-8542   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: CRO...  M15-536|2018-000313-20   \n",
       "2  Allocation: NA|Intervention Model: SINGLE_GROU...         IIT2024-037-002   \n",
       "3  Allocation: NA|Intervention Model: SINGLE_GROU...              SaINT-ov02   \n",
       "4          Observational Model: |Time Perspective: p        YingZhou 2024-10   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2023-09-15              2027-03-15      2027-09-15   2023-11-07   \n",
       "1  2021-11-15              2021-11-16      2021-11-16   2018-01-17   \n",
       "2  2025-06-01              2026-12-31      2026-12-31   2024-11-25   \n",
       "3  2022-04-20              2024-11-30      2024-11-30   2021-12-15   \n",
       "4  2025-01-01              2027-12-31      2030-12-31   2024-10-15   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2023-11-07   \n",
       "1                  NaN          2021-12-08   \n",
       "2                  NaN          2024-11-25   \n",
       "3                  NaN          2022-04-26   \n",
       "4                  NaN          2024-10-15   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  Azienda Socio Sanitaria Territoriale (ASST) La...             NaN  \n",
       "1                                                NaN             NaN  \n",
       "2                                                NaN             NaN  \n",
       "3  Saitama Medical Uiversity International Medica...             NaN  \n",
       "4      Anhui Provincal Hospital, Hefei, Anhui, China             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
